DHSCX
Price
$23.74
Change
+$0.19 (+0.81%)
Updated
Jan 17 closing price
Net Assets
227.98M
VISVX
Price
$49.06
Change
+$0.22 (+0.45%)
Updated
Jan 17 closing price
Net Assets
58.32B
Ad is loading...

DHSCX vs VISVX

Header iconDHSCX vs VISVX Comparison
Open Charts DHSCX vs VISVXBanner chart's image
Diamond Hill Small Cap I
Price$23.74
Change+$0.19 (+0.81%)
VolumeN/A
Net Assets227.98M
Vanguard Small Cap Value Index I
Price$49.06
Change+$0.22 (+0.45%)
VolumeN/A
Net Assets58.32B
DHSCX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DHSCX vs. VISVX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHSCX is a Hold and VISVX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 58.3B vs. DHSCX (228M). DHSCX (1.97) and VISVX (1.90) have matching dividends . DHSCX was incepted earlier than VISVX: DHSCX (24 years) vs VISVX (27 years). DHSCX is a more actively managed with annual turnover of: 41.00 vs. VISVX (16.00). DHSCX has a lower initial minimum investment than VISVX: DHSCX (2500) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 18.46 vs. DHSCX (10.50). VISVX return over 5 years is better than : 50.22 vs. DHSCX (-17.66).
DHSCXVISVXDHSCX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years27 years-
Gain YTD3.1733.19799%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets228M58.3B0%
Annual Yield % from dividends1.971.90104%
Returns for 1 year10.5018.4657%
Returns for 3 years-25.0116.97-147%
Returns for 5 years-17.6650.22-35%
Returns for 10 years-16.56109.01-15%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRVL124.767.18
+6.11%
Marvell Technology
CDXS5.000.08
+1.63%
Codexis
AGNC9.610.06
+0.63%
AGNC Investment Corp
VRTS210.08-0.91
-0.43%
Virtus Investment Partners
CTMX0.84-0.01
-0.84%
CytomX Therapeutics